Stericycle Inc (SRCL) Cut to Underperform at Robert W. Baird
Robert W. Baird cut shares of Stericycle Inc (NASDAQ:SRCL) from a neutral rating to an underperform rating in a research note published on Friday, May 5th. The brokerage currently has $73.00 target price on the business services provider’s stock, down from their previous target price of $74.00.
Several other research firms have also recently issued reports on SRCL. Zacks Investment Research upgraded Stericycle from a sell rating to a hold rating in a report on Saturday, February 18th. Royal Bank of Canada set a $74.00 price objective on Stericycle and gave the stock a sell rating in a report on Saturday, January 21st. Barclays PLC initiated coverage on Stericycle in a report on Thursday, April 13th. They issued an overweight rating and a $100.00 price objective on the stock. Stifel Nicolaus set a $90.00 price objective on Stericycle and gave the stock a buy rating in a report on Monday, February 6th. Finally, Jefferies Group LLC reiterated a buy rating and issued a $108.00 price objective on shares of Stericycle in a report on Thursday, February 16th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company. Stericycle has a consensus rating of Hold and a consensus target price of $82.17.
Stericycle (NASDAQ:SRCL) traded up 0.10% during trading on Friday, hitting $83.84. The stock had a trading volume of 73,441 shares. The company has a market cap of $7.15 billion, a price-to-earnings ratio of 43.69 and a beta of 0.08. Stericycle has a 52-week low of $71.52 and a 52-week high of $107.74. The firm’s 50-day moving average price is $84.15 and its 200-day moving average price is $79.72.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, May 4th. The business services provider reported $1.09 EPS for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.04. Stericycle had a return on equity of 15.33% and a net margin of 7.52%. The firm had revenue of $892.40 million for the quarter, compared to analysts’ expectations of $874.34 million. During the same period last year, the firm earned $1.11 EPS. The company’s quarterly revenue was up 2.1% on a year-over-year basis. Analysts predict that Stericycle will post $4.63 EPS for the current fiscal year.
In other news, Director Mike S. Zafirovski purchased 2,920 shares of Stericycle stock in a transaction dated Thursday, February 23rd. The shares were purchased at an average price of $85.67 per share, with a total value of $250,156.40. Following the transaction, the director now owns 2,920 shares in the company, valued at $250,156.40. The purchase was disclosed in a document filed with the SEC, which is available through this link. 3.30% of the stock is currently owned by insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Bank of Nova Scotia purchased a new stake in shares of Stericycle during the first quarter worth about $1,452,000. Point72 Asset Management L.P. purchased a new stake in shares of Stericycle during the first quarter worth about $3,357,000. HighTower Advisors LLC raised its stake in shares of Stericycle by 0.5% in the first quarter. HighTower Advisors LLC now owns 7,604 shares of the business services provider’s stock worth $627,000 after buying an additional 41 shares during the last quarter. Credit Suisse AG raised its stake in shares of Stericycle by 40.3% in the first quarter. Credit Suisse AG now owns 512,173 shares of the business services provider’s stock worth $42,454,000 after buying an additional 147,084 shares during the last quarter. Finally, Tudor Investment Corp ET AL raised its stake in shares of Stericycle by 63.4% in the first quarter. Tudor Investment Corp ET AL now owns 5,664 shares of the business services provider’s stock worth $469,000 after buying an additional 2,197 shares during the last quarter. 94.49% of the stock is currently owned by hedge funds and other institutional investors.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Stock Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related stocks with our FREE daily email newsletter.